Researchers used single-molecule imaging to compare the genome-editing tools CRISPR-Cas9 and TALEN. Their experiments revealed that TALEN is up to five times more efficient than CRISPR-Cas9 in parts of the genome, called heterochromatin, that are densely packed. Fragile X syndrome, sickle cell anemia, beta-thalassemia and other diseases are the result of genetic defects in the heterochromatin.
from Latest Science News -- ScienceDaily https://ift.tt/3iSqRfw
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment